María L. Amador

An <i>In vivo</i> Platform for Translational Drug Development in Pancreatic Cancer

Belén Rubio‐Viqueira, Antonio Jimeno, George Cusatis et al. · Clinical Cancer Research · 2006 · 411 citations · Full text

An Epidermal Growth Factor Receptor Intron 1 Polymorphism Mediates Response to Epidermal Growth Factor Receptor Inhibitors

María L. Amador, Darin Oppenheimer, Sofía Perea et al. · Cancer Research · 2004 · 242 citations · Full text

A prospective phase II trial of erlotinib in advanced non-small cell lung cancer (NSCLC) patients (p) with mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR)

Luis Paz‐Ares, J. M. Sanchez, A. García et al. · Journal of Clinical Oncology · 2006 · 162 citations

Advanced Nsclc, Medicine, Tyrosine Kinase +14

Epidermal Growth Factor Receptor Dynamics Influences Response to Epidermal Growth Factor Receptor Targeted Agents

Antonio Jimeno, Belén Rubio‐Viqueira, María L. Amador et al. · Cancer Research · 2005 · 105 citations · Full text

Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy

Ricardo Hitt, Eva Ciruelos, María L. Amador et al. · European Journal of Cancer · 2004 · 63 citations

Advanced Head, Medicine, Prognostic Value +10